LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.

LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
复制标题

DOI:
10.18632/oncotarget.3457
复制
发表时间:
2015-05-10
期刊:
影响因子:
--
通讯作者:
Bai XZ
Bai XZ
中科院分区:
其他
文献类型:
--
作者:
Shi SJ;Wang LJ;Yu B;Li YH;Jin Y;Bai XZ

文献摘要

参考文献

被引文献

相似文献

曲妥珠单抗耐药是her2阳性乳腺癌患者死亡的主要原因,TGF-β诱导的上皮-间质转化(EMT)在曲妥珠单抗耐药中的作用已得到证实,但lncrna在曲妥珠单抗耐药中的作用尚不清楚。在这里,我们产生了曲妥珠单抗耐药的乳腺癌细胞,与亲本细胞相比,其侵袭性增加,并观察到这些细胞中强劲的上皮-间质转化(EMT)和持续升高的TGF-β信号传导。我们发现TGF-β激活的长链非编码RNA (lnc-ATB)是TR SKBR-3细胞和TR乳腺癌患者组织中最显著上调的lncRNA。我们发现lnc-ATB通过竞争性抑制miR-200c,上调ZEB1和ZNF-217,进而诱导EMT,从而促进乳腺癌的曲妥珠单抗耐药和侵袭转移级联。此外,我们还发现lnc-ATB高水平与乳腺癌患者曲妥珠单抗耐药相关。因此,这些研究结果表明,lncRNA-ATB作为TGF-β信号传导的介质,可能使乳腺癌患者易发生EMT和曲妥珠单抗耐药。
Trastuzumab resistance is leading cause of mortality in HER2-positive breast cancers, and the role of TGF-β-induced epithelial-mesenchymal transition (EMT) in trastuzumab resistance is well established, but the involvement of lncRNAs in trastuzumab resistance is still unknown. Here, we generated trastuzumab-resistant breast cancer cells with increased invasiveness compared with parental cells, and observed robust epithelial–mesenchymal transition (EMT) and consistently elevated TGF-β signaling in these cells. We identified long noncoding RNA activated by TGF-β (lnc-ATB) was the most remarkably upregulated lncRNA in TR SKBR-3 cells and the tissues of TR breast cancer patients. We found that lnc-ATB could promote trastuzumab resistance and invasion-metastasis cascade in breast cancer by competitively biding miR-200c, up-regulating ZEB1 and ZNF-217, and then inducing EMT. In addition, we also found that the high level of lnc-ATB was correlated with trastuzumab resistance of breast cancer patients. Thus, these findings suggest that lncRNA-ATB, a mediator of TGF-β signaling, could predispose breast cancer patients to EMT and trastuzumab resistance.
DOI: 10.3390/genes5030804
发表时间: 2014-09-11
期刊: Genes
影响因子: 3.5
作者:
Hilmarsdottir B;Briem E;Bergthorsson JT;Magnusson MK;Gudjonsson T
通讯作者: Gudjonsson T
DOI: 10.18632/oncotarget.2454
发表时间: 2014-10-30
期刊: Oncotarget
影响因子: --
作者:
Su X;Malouf GG;Chen Y;Zhang J;Yao H;Valero V;Weinstein JN;Spano JP;Meric-Bernstam F;Khayat D;Esteva FJ
通讯作者: Esteva FJ
DOI: 10.3322/caac.21208
发表时间: 2014-01-01
影响因子: 254.7
作者:
Siegel, Rebecca;Ma, Jiemin;Jemal, Ahmedin
通讯作者: Jemal, Ahmedin
DOI: 10.1073/pnas.0308090100
发表时间: 2004-02-03
影响因子: 11.1
作者:
Seton-Rogers, SE;Lu, Y;Brugge, JS
通讯作者: Brugge, JS
DOI: 10.1200/jco.2010.33.8889
发表时间: 2012-02-20
影响因子: 45.3
作者:
Niikura, Naoki;Liu, Jun;Ueno, Naoto T.
通讯作者: Ueno, Naoto T.